Drug intelligence / Profile preview

ethoxzolamide

Development stage
Unknown
Lead developer
Pfizer
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Ethoxzolamide is a sulfonamide small molecule that acts as a carbonic anhydrase inhibitor. It is used primarily in the treatment of glaucoma and duodenal ulcers and as a diuretic. Ethoxzolamide may also be used in some forms of epilepsy. Its mechanism involves inhibition of carbonic anhydrase enzymes (notably carbonic anhydrase I), which decreases reabsorption of water, sodium, potassium, and bicarbonate in the proximal renal tubules—leading to its diuretic effect—and reduces intraocular pressure by decreasing aqueous humor production in the eye. Inhibition within the central nervous system increases seizure threshold[1][2][4][5].

Other names
6-ethoxy-1,3-benzothiazole-2-sulfonamideethoxazolamide
02

Targets

CA1 (Carbonic anhydrase 1)CA2 (Carbonic Anhydrase 2)CA12 (Carbonic anhydrase XII)CA14 (Carbonic Anhydrase 14)CA4 (Carbonic anhydrase 4)

Beyond the preview

Go deeper on ethoxzolamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ethoxzolamide.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call